文献速递腹部介入技术与安全PETCT

肝细胞癌肝移植患者的正电子发射断层扫描/计算机断层扫描:有用、必要还是无关?

Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant?
PubMed 文献 · Eur J Radiol · 2017-03-23

本文综述文献,评估PET在肝细胞癌肝移植患者中的预后价值。符合米兰标准的患者移植后生存与无肝硬化、相似肿瘤分期行肝切除者相当。PET作为无创工具可提供肿瘤生物学侵袭性信息,但综述旨在识别其作为预后工具的优势与不足。

要点

  • 米兰标准为单个肿瘤结节直径小于5厘米或最多3个结节且最大不超过3厘米。
  • 符合米兰标准者肝移植后生存与相似分期无肝硬化行肝切除者相当。
  • 综述目的为识别PET作为肝细胞癌肝移植后预后工具的优势与不足。

核心结论

  • 本综述旨在识别PET作为肝细胞癌患者肝移植后预后工具的优势与不足。

研究设计与样本

  • 综述文献,检索范围与纳入文献数量原文未报告。

诊断标准与关键数值

  • 米兰标准:单个肿瘤结节直径小于5厘米,或最多3个结节且最大不超过3厘米。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Hepatocellular Carcinoma (HCC) is an aggressive tumor entity, with the only curative options being surgical resection or orthotopic liver transplantation (OLT). The presence of one single tumor nodule of less than 5 centimeters diameter or a maximum of 3 nodules, with the largest of these not exceeding 3 centimeters (Milan criteria) constitute the clinical situation in which the best results for OLT in patients with HCC have been achieved. The survival of patients fulfilling the Milan criteria after transplantation is comparable to patients with similar tumor stages without cirrhosis, undergoing hepatic resection. The application of PET in oncology has become increasingly common in the last decade as it is a non-invasive tool that also gathers information about the degree of the biological aggressiveness of the tumor. The objective of this study was to perform a review of the literature, identifying the strengths and weaknesses of the PET as a prognostic tool in patients with HCC after OLT.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Cascales-Campos PA, Romero PR, Schneider MA, et al. Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant? Eur J Radiol. 2017. PMID: 28629563. doi:10.1016/j.ejrad.2017.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。